Researchers discover key to immune cell's 'internal guidance' system

February 5, 2012

University of British Columbia researchers have discovered the molecular pathway that enables receptors inside immune cells to find, and flag, fragments of pathogens trying to invade a host.

The discovery of the role played by the molecule CD74 could help immunologists investigate treatments that offer better immune responses against cancers, , and lead to more efficient vaccines.

The findings are published in this week's edition of .

"This could ultimately lead to a blueprint for improving the performance of a variety of vaccines, including those against HIV, tuberculosis and malaria," says UBC biologist Wilfred Jefferies, whose lab conducted the study. "This detailed understanding of the role of CD74 may also begin to explain differences in immune responses between individuals that could impact personalized medical options in the future."

CD74 is an important piece of inside dendritic cells – which regulate mammalian primary immune responses. possess specialized pathways that enable them to sense and then respond to foreign threats. Until now no one has been able to piece together the circuitry which enables a cellular receptor – Major Histocompatability Class I (MHC I) – inside the cells to find and 'collide' with foreign invaders.

The key finding of this work is the discovery of the guiding role played by CD74 to link MHC I receptors to compartments containing invading pathogens within the immune cell. This sophisticated circuit allows the immune cell to recognize and signal the presence of a pathogen in the body and to alert T immune fighter cells. The T-cells respond by dividing and attacking infected cells, destroying the pathogen.

Jefferies' team used 'knock-out' mice that had been genetically modified to lack the CD74 function to uncover the role of the molecule. The team--which includes research associate Genc Basha, postdoctoral fellow Anna Reinicke, graduate students Kyla Omilusik and Ana Chavez-Steenbock1, undergraduate student Nathan Lack, and technician Kyung Bok Choi –then confirmed their findings using biochemical analysis.

Explore further: T-cell discovery holds promise for organ transplant and immunodeficiency treatment

More information: The Nature Immunology study is available at: dx.doi.org/10.1038/ni.2225

Related Stories

T-cell discovery holds promise for organ transplant and immunodeficiency treatment

August 23, 2011
University of British Columbia researchers have solved a long-standing mystery surrounding the activation of T-cells, white blood cells that find and kill viruses and bacteria but also participate in the rejection of transplanted ...

Skin sentry cells promote distinct immune responses

July 21, 2011
A new study reveals that just as different soldiers in the field have different jobs, subsets of a type of immune cell that polices the barriers of the body can promote unique and opposite immune responses against the same ...

Recommended for you

Genetic immune deficiency could hold key to severe childhood infections

July 18, 2017
A gene mutation making young children extremely vulnerable to common viruses may represent a new type of immunodeficiency, according to a University of Queensland researcher.

What are the best ways to diagnose and manage asthma?

July 18, 2017
What are the best ways to diagnose and manage asthma in adults? This can be tricky because asthma can stem from several causes and treatment often depends on what is triggering the asthma.

Large multi-ethnic study identifies many new genetic markers for lupus

July 17, 2017
Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus.

Study finds molecular explanation for struggles of obese asthmatics

July 17, 2017
A large, bouquet-shaped molecule called surfactant protein A, or SP-A, may explain why obese asthma patients have harder-to-treat symptoms than their lean and overweight counterparts, according to a new study led by scientists ...

Team identifies potential cause for lupus

July 14, 2017
Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus. A better ...

Immunosuppression underlies resistance to anti-angiogenic therapy

July 14, 2017
A Massachusetts General Hospital (MGH) research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels. In their report ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

Cynical1
not rated yet Feb 06, 2012
Another important "bit" in the long "byte" of knowledge.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.